$192.91+33.04% · 3M
Moving avg
1W-3.48%
1M+1.50%
3M+33.04%
6M+65.76%
YTD+43.59%
1Y+98.10%
3Y+13.34%
5Y-61.12%
52-week range
$88.0094% of range$199.14
Company health
Value0/6
Growth4/6
Profitability5/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (3399%)
Risks
- Trades 14% above the average analyst target
Key statistics
Valuation
Market cap
$29.19B
Enterprise value
$30.12B
P/E ratio (TTM)
34.20x
P/S ratio (TTM)
6.53x
EV/EBITDA
21.03x
Per share & returns
EPS (TTM)
$5.58
Dividend yield
0.00%
Beta (1Y)
1.47
30-day change
+1.50%
Trading
Volume (24h)
1.23M
Previous close
$192.84
Shares outstanding
151.30M
About Illumina, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
ILMN
Illumina, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ (United States) and trade under the ticker ILMN.
Frequently asked questions
What is Illumina, Inc.'s market cap?
Illumina, Inc. (ILMN) has a market capitalization of $29.19B.
What is Illumina, Inc.'s P/E ratio?
Illumina, Inc. trades at a price-to-earnings (P/E) ratio of 34.20.
What exchange does ILMN trade on?
ILMN trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap